Nov. 26, 2024 — Tirzepatide, a new injectable weight-loss drug, reduced the risk of diabetes in patients with obesity and prediabetes by more than 90% over a three-year period, compared with ...
30, 2024 — Young people with severe obesity who underwent weight-loss ... of per- and polyfluoroalkyl substances (PFAS) during pregnancy may experience long-term weight gain and heart problems ...